Leptin receptor antagonist peptide demonstrates efficacy against triple negative brea
A new peptide developed by researchers in Temple University's College of Science and Technology has demonstrated efficacy against triple negative breast cancer.
More... |
All times are GMT -7. The time now is 02:11 PM. |
Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2024, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007 - 2021